Associação Fundo de Incentivo à Pesquisa   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Sao Paulo Brazil (1970)

Organization Overview

First Clinical Trial
2007
NCT00912457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AFIP / UNIFESP | AFIP/ UNIFESP | Associação Fundo de Incentivo a Pesquisa | Associação Fundo de Incentivo à Pesquisa

Active Ingredients

Drugs in Phase 4 Trials (3)

donepezil (aricept) (2 trials)

gabapentin (neurontin) (1 trial)

zolpidem (ambien) (2 trials)

Drugs in Phase 3 Trials (2)

linseed oil (1 trial)

paraffin oil (1 trial)

Drugs in Phase 2 Trials (1)

ramelteon (rozerem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Apnea (Phase 4)

Behavior, Addictive (Phase 3)

Lung Injury (Phase 2)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Sleep Deprivation (Phase 4)

Sleepiness (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 6